slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
216,871-216,900 of 319,975
18
The slide uses a photo of a launch site with callouts pointing to specific infrastructure elements.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
19
The slide emphasizes the portability and operational efficiency of the launch system.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
20
The slide highlights vertical integration and automated manufacturing as a competitive advantage.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
21
Uses concentric circles to represent TAM/SAM market sizing.Astra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
22
Astra | Investor Presentation Deck | 22 slidesAstra | Investor Presentation Deck | 22 slides · Astra
Pitch deck Investor relations 1 hit
01
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
02
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
03
Slide 03 of the deck.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The chart uses a horizontal bar format to represent the progress of drug candidates through clinical phases.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
05
The slide uses a grid-based timeline/milestone tracker for multiple parallel programs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
07
Includes a map of global disease burden and specific clinical trial milestones.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
08
Includes two distinct charts: a scatter/error bar plot for Phase 1 and a bar chart for the Canine Model.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
09
The slide demonstrates an inverted U-shaped dose response curve.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
10
Includes Cohen's d effect sizes and qEEG data markers.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
11
The slide uses a numbered list to highlight key safety findings.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
12
The slide uses a standard clinical trial flow diagram showing randomization into three arms (40mg, 20mg, placebo) over a 6-week period.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
13
Slide 13 of the deck.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
14
Includes a map of global disease burden and key product features.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
15
Includes a stray chat message overlay in the middle of the slide.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
16
The slide uses a process flow diagram to represent the three parts of the study design.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
17
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
18
Includes a map of global disease burden and key epidemiological metrics for OUD.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
19
The chart displays HCQ-29 subscale scores over time (Pre-dose, Discharge, 1 Month) for four dimensions of craving.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
20
Includes cohort structure, safety monitoring parameters, and specific clinical outcomes regarding plasma levels, adverse events, and QTc prolongation.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
21
The table uses checkmarks to indicate the presence of specific therapeutic benefits across different drug classes.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
22
Slide 22 in the deck.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
23
Includes a map of global disease burden and key product specs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
24
Includes definitions for PK/PD, qEEG, and BID in the footer.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
25
The slide uses a numbered list to highlight key safety takeaways alongside detailed data tables.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit